Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,996	2,782	2,876	2,436	4,038	-
Market Cap Growth	44.72%	-3.27%	18.06%	-39.66%	-	-
Enterprise Value	3,818	2,604	2,737	2,281	3,756	-
Last Close Price	60.40	42.05	43.09	36.34	60.06	-
PE Ratio	57.74	35.28	70.37	67.88	90.30	-
PS Ratio	14.48	9.99	12.46	12.48	26.26	-
PB Ratio	6.03	3.98	4.52	4.04	7.01	-
P/TBV Ratio	6.68	4.37	5.08	4.42	7.80	-
P/FCF Ratio	61.82	33.43	42.55	-	-	-
P/OCF Ratio	40.08	23.91	26.71	50.43	60.71	-
EV/Sales Ratio	13.83	9.35	11.85	11.68	24.43	-
EV/EBITDA Ratio	35.13	23.11	40.41	58.51	113.22	-
EV/EBIT Ratio	50.22	29.93	61.91	88.62	139.08	-
EV/FCF Ratio	59.06	31.29	40.48	-	-	-
Debt / Equity Ratio	0.00	0.00	0.08	0.14	0.19	0.14
Debt / EBITDA Ratio	0.00	0.01	0.77	2.00	3.15	1.55
Debt / FCF Ratio	0.01	0.01	0.79	-	-	-
Asset Turnover	0.37	0.35	0.30	0.26	0.26	0.31
Inventory Turnover	1.84	1.90	1.50	1.24	1.45	1.28
Quick Ratio	5.75	4.65	3.51	2.49	7.25	4.03
Current Ratio	8.03	6.58	3.96	2.91	7.70	4.49
Return on Equity (ROE)	12.83%	11.81%	6.60%	6.07%	9.76%	11.47%
Return on Assets (ROA)	7.54%	6.86%	3.61%	2.16%	2.83%	4.06%
Return on Capital (ROIC)	8.44%	7.82%	4.02%	2.35%	3.14%	4.64%
Return on Capital Employed (ROCE)	12.40%	11.60%	6.10%	3.90%	3.90%	6.50%
Earnings Yield	1.71%	2.83%	1.42%	1.47%	1.11%	-
FCF Yield	1.62%	2.99%	2.35%	-3.60%	-2.14%	-
Dividend Yield	0.70%	-	0.93%	0.55%	0.17%	-
Payout Ratio	39.84%	34.41%	37.38%	22.43%	-	-
Buyback Yield / Dilution	2.00%	0.33%	0.80%	-17.43%	-14.83%	0.28%
Total Shareholder Return	2.71%	0.33%	1.73%	-16.88%	-14.66%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.